Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1998, p. 1330-1332, Vol. 36, No. 5
Departments of
Medicine1 and
Pathology,
Received 29 September 1997/Returned for modification 8 December
1997/Accepted 6 February 1998
A simple screening method for fluconazole susceptibility of
Cryptococcus neoformans using 2% dextrose Sabouraud
dextrose agar (SabDex) with fluconazole was compared to the National
Committee for Clinical Laboratory Standards (NCCLS) broth macrodilution method. By this method, fluconazole-susceptible C. neoformans isolates are significantly smaller on medium with
fluconazole than on fluconazole-free medium. Isolates with decreased
susceptibility have normal-size colonies on medium containing
fluconazole. The 48-h NCCLS broth macrodilution MICs (NCCLS MICs) for
isolates with normal-size colonies on 8- or 16-µg/ml fluconazole
plates were predicted to be
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Comparative Evaluation of National Committee for
Clinical Laboratory Standards Broth Macrodilution and Agar Dilution
Screening Methods for Testing Fluconazole Susceptibility of
Cryptococcus neoformans
8 or
16 µg/ml, respectively. On
medium with 16 µg of fluconazole per ml, all strains (84 of 84) for
which the NCCLS MICs were <16 µg/ml were correctly predicted, as
were all isolates (7 of 7) for which the MICs were
16 µg/ml. Agar dilution appears to be an effective screening method for fluconazole resistance in C. neoformans.
*
Corresponding author. Mailing address: Department of
Medicine, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX
78284-7881. Phone: (210) 567-4823. Fax: (210) 567-4670. E-mail: PATTERSON{at}UTHSCSA.EDU.
Journal of Clinical Microbiology, May 1998, p. 1330-1332, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|